+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Afinitor"

Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Pancreatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Pancreatic Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Pancreatic Cancer Diagnostic Market Report 2025 - Product Thumbnail Image

Pancreatic Cancer Diagnostic Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Afinitor is a drug used to treat certain types of lung cancer. It is a type of targeted therapy, which works by blocking certain proteins that help cancer cells grow and divide. It is used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is no longer responding to other treatments. Afinitor is also used to treat certain types of kidney cancer. It is usually taken in combination with other drugs. Afinitor is a relatively new drug, and is still in the early stages of development. It is not yet widely available, and is only approved for use in certain countries. However, it is gaining popularity as a treatment for lung cancer, and is being studied in clinical trials for other types of cancer. The Afinitor market is highly competitive, with several companies developing and marketing the drug. These include Novartis, Pfizer, and AstraZeneca. Other companies are also researching and developing similar drugs, such as Merck and Bristol-Myers Squibb. Show Less Read more